NBOG focus turns to notified body role in new and revised regulations
This article was originally published in RAJ Devices
Following the publication of a number of key documents related to how notified bodies should audit their medical device clients1, the European Commission’s Notified Bodies Operations Group is now anticipating the planned revision of the In Vitro Diagnostics Directive (Directive 98/79/EC)2. It is looking at conformity assessment and related notified body issues within this context.
You may also be interested in...
Where are the biggest challenges for notified bodies and manufacturers now there is some experience with the MDR, and can the sector manage the new regulatory requirements successfully?
The European Commission has finally published detailed guidance on the EU IVDR’s classification rules. The IVDR’s completely new classification regime means guidance is urgently needed.
Do you know how to avoid the pitfalls when it comes to clinical evidence under the MDR? Or whether evidence gathered outside the US counts? Amie Smirthwaite of Maetrics answers these and other pivotal questions in this third and final part of an interview series with Medtech Insight.